Aurinia Pharmaceuticals, Inc. (NASDAQ:AUPH) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET

Company Participants

Andrea Christopher - Head, Corporate Communications & IR
Peter Greenleaf - President, CEO & Director
Greg Keenan - Chief Medical Officer
Joe Miller - CFO

Conference Call Participants

Stacy Ku - TD Cowen
Maurice Raycroft - Jefferies
Olivia Brayer - Cantor Fitzgerald
Will Soghikian - Leerink Partners

Operator

Greetings, and welcome to Aurinia Pharmaceuticals Third Quarter 2024 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Andrea Christopher, Head of Corporate Communications and Investor Relations for Aurinia Pharmaceuticals. Thank you. You may now begin.

Andrea Christopher

Thank you, operator, and thank you to everyone for joining today's call and webcast. Joining me on the call this morning are Peter Greenleaf, Aurinia's President and Chief Executive Officer; Joe Miller, our Chief Financial Officer; and Dr. Greg Keenan, our Chief Medical Officer. Today, we will review and discuss Aurinia's 2024 third quarter financial and operational results as communicated in the company's press release issued this morning. The company also filed its quarterly financial statements on Form 10-Q this morning. For more information, please refer to Aurinia's filings with the U.S. Securities and Exchange Commission and Canadian securities authorities, which are also available on Aurinia's website at auriniapharma.com.

During today's call, Aurinia may make forward-looking statements based on current expectations. These forward-looking statements are subject to a number of significant risks and uncertainties, and actual results may differ materially. For a discussion of factors that could affect Aurinia's future financial results and business, please refer to the disclosures in Aurinia's press release, its quarterly report on Form 10-Q, and its annual report on Form 10-K, and all of its recent filings with the U.S. Securities and Exchange Commission and Canadian securities authorities. Please note that all statements made during today's call are current as of today, November 7, 2024, unless otherwise noted and are based upon information currently available to us. Except as required by law, Aurinia assumes no obligation to update any such statements.

Now let me turn the call over to Aurinia's President and CEO, Peter Greenleaf. Peter?

Peter Greenleaf

Thanks, Andrea, and good morning, everyone. I want to thank everybody for joining us on the call today. On this morning's call, I'll provide the details on our third quarter business metrics and how we are preparing for the rest of the year. I'll then turn the call over to Joe Miller, our CFO, to provide additional details on our financial results.